About the Company
We do not have any company description for Seer, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Laboratory Analytical Instruments
Employees
157
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Seer, Inc.
Seer Inc (SEER) Q2 2025: Everything You Need To Know Ahead Of Earnings
Seer Inc (NASDAQ:SEER) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate for Q2 2025 revenue is ...
Seer, Inc. Reports Strong First Quarter 2025 Financial Results ... - Nasdaq
May 13, 2025 — 04:15 pm EDT Written by None for Quiver Quantitative -> Seer, Inc. reports Q1 2025 revenue of $4.2 million, up 37%, amid ongoing macroeconomic challenges. Quiver AI Summary ...
Seer, Inc. to Report Q1 2025 Financial Results on May 13, 2025
Seer, Inc., a life sciences company specializing in proteomics, announced that it will release its financial results for the first quarter of 2025 on May 13, 2025.
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report ...
Seer Technology Access Center Provides Unprecedented Scale and Depth of ...
REDWOOD CITY, Calif., June 02, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, announced today that PrognomiQ ...
Seer Inc - Ordinary Shares - Class A SEER Overview - U.S. News
Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and ...
Seer Inc. (SEER) - News - Insider Monkey
Seer, Inc. (NASDAQ:SEER) Q4 2024 Earnings Call Transcript Operator: Good day and thank you for standing by. Welcome to the Seer Fourth Quarter and Full-Year 2024 Earnings Conference Call.
Seer, Inc. (SEER) Reports Q2 Loss, Beats Revenue Estimates
Seer, Inc. (SEER) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to a loss of $0.35 per share a year ago. These figures are ...
Seer Debuts with Proprietary Proteomics Platform to Enable Early ...
Seer, Inc. launched today to capture and translate molecular insights from the proteome to enable early detection of cancer and neurological diseases.
Similar Companies
Loading the latest forecasts...